Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
Danielle Sambo, Min Lin, Anthony Owens, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Methamphetamine Use and Cardiovascular Disease
Christopher G. Kevil, Nicholas E. Goeders, Matthew D. Woolard, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2019) Vol. 39, Iss. 9, pp. 1739-1746
Open Access | Times Cited: 217
Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases
Daniel A. Ryskamp, Svetlana A. Korban, Vladimir Zhemkov, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 175
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 163
Methamphetamine neurotoxicity, microglia, and neuroinflammation
Fatemeh Shaerzadeh, Wolfgang J. Streit, Soomaayeh Heysieattalab, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 132
Methamphetamine-Induced Neuronal Damage: Neurotoxicity and Neuroinflammation
Buyun Kim, Jangmi Yun, Byoungduck Park
Biomolecules & Therapeutics (2020) Vol. 28, Iss. 5, pp. 381-388
Open Access | Times Cited: 82
Sigmar1’s Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology
Richa Aishwarya, Chowdhury S. Abdullah, Mahboob Morshed, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 79
The Crosstalk Between Neurons and Glia in Methamphetamine-Induced Neuroinflammation
Sai Shi, Tianzhen Chen, Min Zhao
Neurochemical Research (2022) Vol. 47, Iss. 4, pp. 872-884
Closed Access | Times Cited: 42
Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine
Shao-Ming Wang, Hsiang-En Wu, Yuko Yasui, et al.
Autophagy (2022) Vol. 19, Iss. 1, pp. 126-151
Open Access | Times Cited: 39
Gut microbiota-derived short-chain fatty acids ameliorate methamphetamine-induced depression- and anxiety-like behaviors in a Sigmar-1 receptor-dependent manner
Kai-Kai Zhang, Lijian Chen, Jian-Zheng Yang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 4801-4822
Open Access | Times Cited: 37
Propofol exerts anti-anhedonia effects via inhibiting the dopamine transporter
Xiaona Zhu, Jie Li, Gaolin Qiu, et al.
Neuron (2023) Vol. 111, Iss. 10, pp. 1626-1636.e6
Open Access | Times Cited: 28
Sigma-1 Receptor Specific Biological Functions, Protective Role, and Therapeutic Potential in Cardiovascular Diseases
Ahmed Al‐Maamari, Marwa Sultan, Tao Zhang, et al.
Cardiovascular Toxicology (2025)
Closed Access | Times Cited: 1
Genes, Cognition, and Their Interplay in Methamphetamine Use Disorder
Raheela Khan, Alyna Turner, Michael Berk, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 306-306
Open Access | Times Cited: 1
The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction
Danielle Sambo, Joseph J. Lebowitz, Habibeh Khoshbouei
Pharmacology & Therapeutics (2018) Vol. 186, pp. 152-167
Open Access | Times Cited: 66
The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson’s Disease
Phillip Mackie, Joseph J. Lebowitz, Leila Saadatpour, et al.
Brain Behavior and Immunity (2018) Vol. 70, pp. 21-35
Open Access | Times Cited: 63
Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays
Hideaki Yano, Alessandro Bonifazi, Min Xu, et al.
Neuropharmacology (2018) Vol. 133, pp. 264-275
Open Access | Times Cited: 61
At the Crossing of ER Stress and MAMs: A Key Role of Sigma-1 Receptor?
Benjamin Delprat, Lucie Crouzier, Tsung‐Ping Su, et al.
Advances in experimental medicine and biology (2019), pp. 699-718
Closed Access | Times Cited: 61
Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function
Chowdhury S. Abdullah, Richa Aishwarya, Shafiul Alam, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 51
New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders
Amy Hauck Newman, Therese Ku, Chloe J. Jordan, et al.
The Annual Review of Pharmacology and Toxicology (2021) Vol. 61, Iss. 1, pp. 609-628
Open Access | Times Cited: 48
Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders
Kinga Sałaciak, Karolina Pytka
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 1114-1136
Open Access | Times Cited: 47
An inhibitory brainstem input to dopamine neurons encodes nicotine aversion
Christine Liu, Amanda J. Tose, Jeroen P. H. Verharen, et al.
Neuron (2022) Vol. 110, Iss. 18, pp. 3018-3035.e7
Open Access | Times Cited: 33
Sigma-1 Receptors in Depression: Mechanism and Therapeutic Development
Peng Ren, Jingya Wang, Nanxi Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
Sigma-1 Receptor Signaling: In Search of New Therapeutic Alternatives for Cardiovascular and Renal Diseases
Francisco Javier Munguía-Galaviz, Alejandra Guillermina Miranda‐Díaz, Miguel Alejandro Cardenas-Sosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1997-1997
Open Access | Times Cited: 22
Mechanism of Manganese Dysregulation of Dopamine Neuronal Activity
Min Lin, Luis M. Colon‐Perez, Danielle Sambo, et al.
Journal of Neuroscience (2020) Vol. 40, Iss. 30, pp. 5871-5891
Open Access | Times Cited: 48
Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity
Douglas R. Miller, Mengfei Bu, Adithya Gopinath, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 379, Iss. 3, pp. 372-385
Open Access | Times Cited: 40
Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases
Ning‐hua Wu, Yu Ye, Bin-bin Wan, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 11, pp. 5649-5666
Closed Access | Times Cited: 35
Page 1 - Next Page

Scroll to top